HomeCompareICVX vs FCPT

ICVX vs FCPT: Dividend Comparison 2026

ICVX yields 13.06% · FCPT yields 6.05%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 FCPT wins by $1.8K in total portfolio value· pulled ahead in Year 10
10 years
ICVX
ICVX
● Live price
13.06%
Share price
$15.31
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$47.3K
Annual income
$2,943.04
Full ICVX calculator →
FCPT
FCPT
● Live price
6.05%
Share price
$23.65
Annual div
$1.43
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.1K
Annual income
$5,775.28
Full FCPT calculator →

Portfolio growth — ICVX vs FCPT

📍 FCPT pulled ahead of the other in Year 10

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodICVXFCPT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ICVX + FCPT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ICVX pays
FCPT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ICVX
Annual income on $10K today (after 15% tax)
$1,110.39/yr
After 10yr DRIP, annual income (after tax)
$2,501.58/yr
FCPT
Annual income on $10K today (after 15% tax)
$514.49/yr
After 10yr DRIP, annual income (after tax)
$4,908.99/yr
At 15% tax rate, FCPT beats the other by $2,407.40/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ICVX + FCPT for your $10,000?

ICVX: 50%FCPT: 50%
100% FCPT50/50100% ICVX
Portfolio after 10yr
$48.2K
Annual income
$4,359.16/yr
Blended yield
9.05%
📊

Analyst Conviction Gap

Where Wall Street is split right now

ICVX
Analyst Ratings
5
Buy
1
Hold
Consensus: Buy
Price Target
$27.00
+76.4% upside vs current
Range: $27.00 — $27.00
Altman Z
22.6
Piotroski
3/9
FCPT
Analyst Ratings
5
Buy
10
Hold
Consensus: Hold
Price Target
$27.00
+14.2% upside vs current
Range: $25.00 — $29.00
Altman Z
1.4
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ICVX buys
0
FCPT buys
0
No recent congressional trades found for ICVX or FCPT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricICVXFCPT
Forward yield13.06%6.05%
Annual dividend / share$2.00$1.43
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8%
Portfolio after 10y$47.3K$49.1K
Annual income after 10y$2,943.04$5,775.28
Total dividends collected$21.0K$24.1K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusBuyHold
Analyst price target$27.00$27.00

Year-by-year: ICVX vs FCPT ($10,000, DRIP)

YearICVX PortfolioICVX Income/yrFCPT PortfolioFCPT Income/yrGap
1$12,006$1,306.34$11,401$700.92+$605.00ICVX
2$14,313$1,465.82$13,064$864.84+$1.2KICVX
3$16,948$1,633.07$15,051$1,072.48+$1.9KICVX
4$19,941$1,807.22$17,442$1,337.22+$2.5KICVX
5$23,324$1,987.33$20,340$1,677.08+$3.0KICVX
6$27,129$2,172.42$23,880$2,116.57+$3.2KICVX
7$31,390$2,361.53$28,241$2,689.36+$3.1KICVX
8$36,141$2,553.64$33,660$3,442.07+$2.5KICVX
9$41,419$2,747.79$40,456$4,439.95+$963.00ICVX
10← crossover$47,261$2,943.04$49,063$5,775.28$1.8KFCPT

ICVX vs FCPT: Complete Analysis 2026

ICVXStock

Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical trial; IVX-A12, a respiratory syncytial virus (RSV) monovalent antigen candidate with RSV/human metapneumovirus (hMPV) bivalent target indication; IVX-241, a vaccine candidate with hMPV target; and IVX-411, an original receptor binding domain (RBD) sequence antigen with SARS-CoV-2 target indication and is under Phase 1/2 clinical trial. The company was incorporated in 2017 and is headquartered in Seattle, Washington.

Full ICVX Calculator →

FCPTREIT

FCPT, headquartered in Mill Valley, CA, is a real estate investment trust primarily engaged in the acquisition and leasing of restaurant properties. The Company seeks to grow its portfolio by acquiring additional real estate to lease, on a net basis, for use in the restaurant and retail industries.

Full FCPT Calculator →
📬

Get this ICVX vs FCPT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ICVX vs SCHDICVX vs JEPIICVX vs OICVX vs KOICVX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.